Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. biomedical data
Show results for
Products
Services
Software

Companies

News
Articles
Books
Videos

Refine by
Date

  • Older

Biomedical Data Articles & Analysis

9 news found

DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting

DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. ...

ByDNAnexus, Inc.


Ondine reports successful US Phase 2 trial data

Ondine reports successful US Phase 2 trial data

Results show a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site infections, in pre-surgical patients Top line results met primary endpoint and showed nasal photodisinfection eliminated or significantly decreased Staphylococcus aureus ( aureus) in 92% of carriers treated per protocol (P<0.001). All of the 319 ...

ByOndine Biomedical Inc


CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data ...

ByCD Genomics


BioLizard and JADBio Announce Partnership

BioLizard and JADBio Announce Partnership

JADBio is a robust Automated Machine Learning platform that allows intuitive, timely, and interactive creation of ML predictive models on BioMedical and Multi-omics data, while allowing for knowledge (biomarker signature) discovery through its vast range of reporting and analysis. ...

ByJADBio


Optimizing and Accelerating COVID-19 Predictive Modeling

Optimizing and Accelerating COVID-19 Predictive Modeling

The Just Add Data Bio (JADBio) platform is an AutoML technology that can be readily applied to low-sample, high-dimensional biomedical data and can produce accurate predictive models with their corresponding biosignatures. ...

ByJADBio


Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

Immunai reasons that adding Nebion’s data will help it improve its machine learning (ML) models by enabling the platform to find drug targets from aggregated public data sets and providing validation data for targets found through other methods. ...

ByImmunai


Longenesis announces Curator platform for privacy-preserving data use for COVID-19 research

Longenesis announces Curator platform for privacy-preserving data use for COVID-19 research

Curator provides an opportunity to search for specific biomedical data by different combinations of descriptive characteristics without revealing personal data. ...

ByLongenesis


Longenesis enters the Singapore market as a participant of 500 Startups Singapore program to accelerate healthcare research in the region

Longenesis enters the Singapore market as a participant of 500 Startups Singapore program to accelerate healthcare research in the region

Longenesis joins the 500 Startups family in a 16-week Singapore-based program designed to accelerate the growth of the best-selected startups through deep market insights, hands-on coaching and exposure to 500’s network of partners, experts, and talent. For the next 4 months, our team will be fully immersed in the Singapore market leveraging the 500 Startups’ network to multiply the ...

ByLongenesis


Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018

Shifa Biomedical Corporation Presents Preclinical Data on P-21, a Novel Orally Active PSCK9 Antagonist, at the American Heart Association (AHA) Meeting, Scientific Sessions 2018

CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Shifa Biomedical Corporation (Shifa), a drug discovery biopharmaceutical company focused on developing novel agents to treat cardiovascular disease and hypercholesteremia, today announced exciting preclinical data involving the company’s pre-clinical candidate, P-21, which interferes with the interaction between ...

ByShifa Biomedical Corporation

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT